14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 251 days ( -70.04 % )
Last Price $9.25 0 %
High/ Low $9.25 - $9.25 0%
Chg 7 Days N/A $9.25 $9.25
Chg 30 Days N/A $9.25 $9.25
Chg 12 mos 93.11 % $4.79 $9.25
Trend - 3 mos N/A Width: 0 %
Trend - 12 mos 8.65 % Width: 62.64 %
Pred. range - 3 mos N/A - N/A -100.00 % - -100.00 %
Pred. range - 12 mos $7.52 - $12.23 -18.72 % - 32.19 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Jul 30, 2021 - 210 days
Long MA avg 12 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 12 mos Buy Jun 02, 2021 - 251 days
Pivot Short Sell May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Kindred Biosciences

Kindred Biosciences Kindred Biosciences, Inc., a development stage biopharmaceutical company, focuses on the development of therapies for pets. The company’s product pipeline consists of small molecules and biologics for a range of indications in dogs, cats, and horses. Its lead product candidates include Zimeta, a pyrazolone anti-inflammatory drug, for the treatment of fever in horses; and KIND-010 for management of weight loss in cats and feline epo for anemia in... KIN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT